DIN 01913670 — TEVA-GLYBURIDE 2.5 MG
TEVA-GLYBURIDE is a tablet of Glyburide marketed by TEVA CANADA LIMITED. The full Glyburide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 01913670
- Brand name
- TEVA-GLYBURIDE
- Active ingredient
- Glyburide
- Strength
- 2.5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Second-generation sulfonylurea (oral hypoglycemic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Glyburide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 01913654 | APO GLYBURIDE TAB 2.5MG | 2.5 MG | TABLET | APOTEX INC | MARKETED |
| 01913662 | APO GLYBURIDE TAB 5MG | 5 MG | TABLET | APOTEX INC | MARKETED |
| 01913689 | TEVA-GLYBURIDE | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |